Is NCT07147517 recruiting in La Jolla, CA?

Yes, NCT07147517 is currently recruiting participants at its La Jolla, CA location. This respiratory infection virus clinical trial is actively enrolling qualified participants.

How do I join the respiratory infection virus clinical trial in La Jolla?

To join this clinical trial in La Jolla, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this La Jolla clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Respiratory Infection Virus Clinical Trial in La Jolla, CA

About This Respiratory Infection Virus Study in La Jolla

The CHARM network will be established through three primary institutions-Beth Israel Deaconess Medical Center (BIDMC), the University of California San Diego (UCSD), and the University of Washington (UW)-along with their subcontracting institutions. At UCSD and partner sites, the CHARM network will be implemented via the PREVENT project. All PREVENT participants will be consented in to Component A0 (Community Testing) and a subset of A0 participants will be invited to participate and will be consented into the other components: Component A (Ongoing Testing); Component A Sub-study (Immunology); Component B (Household Transmission). Component A0 participants (Community testing) will be members of the community who are interested in accessing testing for respiratory infections and will be asked to provide limited information that will then be used for screening for study Components A and/or B. Participants in Component A (Ongoing Testing ) will undergo weekly symptom screening. If they report symptoms, they will be asked to provide a nasal swab and complete illness questionnaires on the day they report symptoms (Day 0) and again on Days 7 and 14. Participants in Component A Sub-study (Immunology) will provide blood and saliva/nasal fluid samples twice a year, as well as before and after infection and/or immunization against priority pathogens. Participants in Component B (Household Transmission) will complete daily symptom questionnaires and nasal swabs for 14 days following enrollment, regardless of symptoms. Those who are symptomatic at enrollment will also complete retrospective daily diaries from symptom onset to the enrollment date. Additionally, they provide blood and/or saliva/nasal fluid samples at enrollment and again 28 days later. For all Components, UCSD will provide PCR test results for SARS-CoV-2, Influenza A/B, and RSV for nasal swab samples.

Sponsor: University of California, San Diego

Who Can Participate

Inclusion Criteria

\- All community members are able to participate in the community testing component.

Exclusion Criteria

\- There is no exclusion criteria and participants will not be excluded based on pregnancy status or age. For Component A: Inclusion:

AND Lives in service area of a recruitment center (i.e., within range of courier pick up)

AND Plans to remain living in a recruitment area for the next 2 years. Exclusion:

Inability to communicate in a language in which consent forms, materials, etc. are available

OR Incarcerated

OR Living in a congregate setting (e.g., assisted living, nursing home, university dormitories with shared bathroom and communal eating facilities)

OR Unable/unwilling to participate in planned data and specimen collections

OR Unable to comply with study procedures, as determined by study investigators

OR Participation in clinical trials of investigational agents for respiratory viral infections during the three months prior to enrollment and for the duration of the study. For Component B: Inclusion: Index case:

Detection of priority respiratory pathogen via laboratory or point-of-care test on the day of eligibility screening or in the previous 5 days, AND

Lives in service area of a recruitment center (i.e., within range of courier pick up), AND

Lives in a household with ≥1 other person and plans to remain in the household for at least the duration of specimen collection (i.e., 14 days), AND

Has not been hospitalized since the date of symptom onset. Household contacts:

Routinely sleep in the same household as index case and slept in household ≥1 night in the 7 days before index case symptom onset, AND

Plan to remain in the household for at least the duration of specimen collection (i.e., 14 days). Household:

There is ≥1 non-ill household member (i.e., asymptomatic and has not tested positive for the virus of the index case) on the day of eligibility screening or in the previous 5 days,

AND all symptomatic persons in the household had a symptom or diagnosis onset date on the day of eligibility screening or in the previous 5 days. Exclusion: Index case:

Lives in a congregate setting (e.g., assisted living, nursing home, university dormitories with shared bathroom and communal eating facilities)

Meet any A1 exclusion criteria Household contacts:

Has been hospitalized any time since date of primary case symptom onset

Meets any A1 exclusion criteria Household:

The enrollment visit occurs \>6 days after the first symptom onset of primary case

The primary case in the household is not enrolled

The primary case has been hospitalized any time after the date of symptom onset

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in La Jolla?

Yes, this clinical trial (NCT07147517) has an active research site in La Jolla, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Respiratory Infection Virus Treatment Options in La Jolla, CA

If you're searching for respiratory infection virus treatment options in La Jolla, CA, this clinical trial (NCT07147517) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory infection virus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all respiratory infection virus clinical trials near you to find additional studies recruiting in your area.

Respiratory Infection Virus Clinical Trial in La Jolla, CA

Expert Care in La Jolla

IRB Approved

No-Cost Care

Apply for This La Jolla Location

Why Participate?

Simple Process